RE:RE:RE:RE:RE:AdiosKeep your facts straight and you may benefit. I have always said that the March journal publication would be beneficail to the share price and that my target of $4 (1500%) is quite attainable in 2015. I never wondered why investors would buy TST - it is a sound spec stock, but I have stated multiple times that I do not think that a buyout by big pharma will take place until after FDA approval. There is a huge difference between individuals putting a few thousand dollars on the table and an exec at big pharma calling for tens of millions of funds to buy out a spec. stock. Everything changes when approval given though. For sure the stock will inch upwards and bounce around a bit until the actual annoucements, Your rantings and those of others do not change timelines nor the basics of the market. Those who collected their 40% are all smiles and happily ignoring the poor boys rantings. This is all just noise what has happened recently. Some new investors are in and some have cashed out. Quote me on this: in 2015 TST at $4.